1. Home
  2. ZUMZ vs FATE Comparison

ZUMZ vs FATE Comparison

Compare ZUMZ & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$28.61

Market Cap

363.1M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

121.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZUMZ
FATE
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.1M
121.1M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
ZUMZ
FATE
Price
$28.61
$1.08
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$18.00
$3.92
AVG Volume (30 Days)
345.8K
1.2M
Earning Date
12-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$916,909,000.00
$7,137,000.00
Revenue This Year
$5.50
N/A
Revenue Next Year
$1.36
N/A
P/E Ratio
$58.03
N/A
Revenue Growth
2.81
N/A
52 Week Low
$11.31
$0.66
52 Week High
$31.70
$1.99

Technical Indicators

Market Signals
Indicator
ZUMZ
FATE
Relative Strength Index (RSI) 63.37 44.42
Support Level $28.30 $1.02
Resistance Level $29.68 $1.19
Average True Range (ATR) 1.16 0.07
MACD -0.18 0.00
Stochastic Oscillator 50.32 29.11

Price Performance

Historical Comparison
ZUMZ
FATE

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: